Rocket Pharmaceuticals Inc (RCKT)

Cost of Revenue

$2.15M

TTM · Period ending: · USD

RCKT logo

RCKT Cost of Revenue

Latest reported$2.15M
RCKT TTM Cost of Revenue ($0.00 → $2.15M)
High-resolution chart · PNG

RCKT cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rocket Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
2,146,000
2,146,000
0
0
0
2,339,000
4,593,000
4,593,000
4,593,000
2,254,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.